205.438.01019 Boehringer Ingelheim Investigational Site — Cleveland, Ohio

205.438.01019 Boehringer Ingelheim Investigational Site is a clinical research site located in Cleveland, Ohio, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

205.438.01019 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Cystic Fibrosis.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 205.438.01019 Boehringer Ingelheim Investigational Site?

205.438.01019 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 205.438.01019 Boehringer Ingelheim Investigational Site conducted?

205.438.01019 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Cystic Fibrosis.

Is 205.438.01019 Boehringer Ingelheim Investigational Site accredited by Crixeo Health?

205.438.01019 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 205.438.01019 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.